Antibacterial activity of novel linear polyamines against Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
New therapeutic options are urgently required for the treatment of Staphylococcus aureus infections. Accordingly, we sought to exploit the vulnerability of S. aureus to naturally occurring polyamines. We have developed and tested the anti-staphylococcal activity of three novel linear polyamines based on spermine and norspermine. Using a panel of genetically distinct and clinically relevant multidrug resistant S. aureus isolates, including the polyamine resistant USA300 strain LAC, compound AHA-1394 showed a greater than 128-fold increase in inhibition against specific S. aureus strains compared to the most active natural polyamine. Furthermore, we show that AHA-1394 has superior biofilm prevention and biofilm dispersal properties compared to natural polyamines while maintaining minimal toxicity toward human HepG2 cells. We examined the potential of S. aureus to gain resistance to AHA-1394 following in vitro serial passage. Whole genome sequencing of two stable resistant mutants identified a gain of function mutation (S337L) in the phosphatidylglycerol lysyltransferase mprF gene. Inactivation of mutant mprF confirmed the importance of this allele to AHA-1394 resistance. Importantly, AHA-1394 resistant mutants showed a marked decrease in relative fitness and increased generation time. Intriguingly, mprF::S337L contributed to altered surface charge only in the USA300 background whereas increased cell wall thickness was observed in both USA300 and SH1000. Lastly, we show that AHA-1394 displays a particular proclivity for antibiotic potentiation, restoring sensitivity of MRSA and VRSA isolates to daptomycin, oxacillin and vancomycin. Together this study shows that polyamine derivatives are impressive drug candidates that warrant further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633 · cited 5×
“Acquisition of ACME distinguishes the highly virulent USA300 community-associated (CA)-MRSA lineage from other CAMRSA lineages and has been proposed to have contributed to the hypervirulence, hyper-transmissibility, and increased propensity to cause skin and soft tissue infections (SSTIs) of USA300 (Diep et al., 2006;…”
BackgroundInfluentialProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175 · cited 3×
“Considering SCVs are typically associated with a fourfold increase in MIC against β-lactams and a 4–8-fold increase in MIC against aminoglycosides (R. A. Proctor et al., 1995; Proctor and von Humboldt, 1998; Proctor et al., 2006), our data indicates the therapeutic potential of AHA-1394 against difficult to eradicate…”
BackgroundPersistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Bayer, A. S., Schneider, T., & Sahl, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06819.x · Cited by 311 · cited 1×
“serving to repel positively charge antimicrobials (Ernst and Peschel, 2011; Bayer et al., 2013).”
Cited by
Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia
Douglas, E. J., Palk, N., Brignoli, T., Altwiley, D., Boura, M., Laabei, M., Recker, M., Cheung, G. Y., Liu, R., Hsieh, R. C., et al. (2023) · eLife · doi:10.7554/elife.87026.3 · Cited by 9
Self-citationExtensive re-modelling of the cell wall during the development of Staphylococcus aureus bacteraemia
Douglas, E. J. A., Palk, N., Brignoli, T., Altwiley, D., Boura, M., Laabei, M., Recker, M., Cheung, G. Y. C., Liu, R., Hsieh, R. C., et al. (2023) · doi:10.7554/elife.87026.2 · Cited by 1
Self-citationExtensive re-modelling of the cell wall during the development of Staphylococcus aureus bacteraemia
Douglas, E. J. A., Palk, N., Brignoli, T., Altwiley, D., Boura, M., Laabei, M., Recker, M., Cheung, G. Y. C., Liu, R., Hsieh, R. C., et al. (2023) · doi:10.1101/2023.02.23.529713
Self-citation
Metadata
- Authors
- Douglas, E. J. A., Alkhzem, A. H., Wonfor, T., Li, S., Woodman, T. J., Blagbrough, I. S., & Laabei, M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-08-22
- Volume
- 13
- Pages
- 948343-948343
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W4292575196
- Cited by
- 26
- References
- 4
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibacterial activity of novel linear polyamines against Staphylococcus aureus. https://app.cochat.ai/papers/10.3389/fmicb.2022.948343
- The paper
- Douglas, E. J. A., Alkhzem, A. H., Wonfor, T., Li, S., Woodman, T. J., Blagbrough, I. S., & Laabei, M. (2022). Antibacterial activity of novel linear polyamines against Staphylococcus aureus. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2022.948343
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.